Flagship Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.78M Buy
1,487
+228
+18% +$233K 0.4% 45
2026
Q1
$981K Sell
1,259
-238
-16% -$241K 0.42% 41
2025
Q4
$1.61M Hold
1,497
0.47% 42
2025
Q3
$1.14M Buy
1,497
+38
+3% +$28.3K 0.38% 48
2025
Q2
$1.14M Buy
1,459
+33
+2% +$25.6K 0.43% 39
2025
Q1
$1.18M Hold
1,426
0.5% 38
2024
Q4
$1.1M Buy
+1,426
New +$1.18M 0.65% 28

Other funds holding LLY

Flagship Wealth Advisors's LLY Position: Q2 2026 in Review

Flagship Wealth Advisors increased its Eli Lilly (LLY) stake by 18% in Q2 2026, buying an estimated $233K and bringing the position to 1,487 shares worth $1.78M. The position accounts for 0.4% of the portfolio, ranked #45.

Flagship Wealth Advisors first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Flagship Wealth Advisors held 1,487 shares of Eli Lilly worth $1.78M as of Q2 2026.
  • Flagship Wealth Advisors bought 228 Eli Lilly shares in Q2 2026, an estimated $233K.
  • Eli Lilly made up 0.4% of Flagship Wealth Advisors's portfolio in Q2 2026, its #45 holding.
  • Flagship Wealth Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Flagship Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.